PL1856140T3 - Związane z matrycą peptydomimetyki o strukturze spinki do włosów ze zwrotem beta wykazujące aktywność hamowania proteaz - Google Patents

Związane z matrycą peptydomimetyki o strukturze spinki do włosów ze zwrotem beta wykazujące aktywność hamowania proteaz

Info

Publication number
PL1856140T3
PL1856140T3 PL05707463T PL05707463T PL1856140T3 PL 1856140 T3 PL1856140 T3 PL 1856140T3 PL 05707463 T PL05707463 T PL 05707463T PL 05707463 T PL05707463 T PL 05707463T PL 1856140 T3 PL1856140 T3 PL 1856140T3
Authority
PL
Poland
Prior art keywords
template
inhibitory activity
protease inhibitory
hairpin peptidomimetics
fixed beta
Prior art date
Application number
PL05707463T
Other languages
English (en)
Inventor
Marco Steven J De
Kerstin Moehle
Heiko Henze
Odile Sellier
Françoise Jung
Frank Gombert
Daniel Obrecht
Christian Ludin
Original Assignee
Polyphor Ltd
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polyphor Ltd, Univ Zuerich filed Critical Polyphor Ltd
Publication of PL1856140T3 publication Critical patent/PL1856140T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL05707463T 2005-02-17 2005-02-17 Związane z matrycą peptydomimetyki o strukturze spinki do włosów ze zwrotem beta wykazujące aktywność hamowania proteaz PL1856140T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2005/001622 WO2006087001A1 (en) 2005-02-17 2005-02-17 Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
EP05707463.5A EP1856140B1 (en) 2005-02-17 2005-02-17 Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity

Publications (1)

Publication Number Publication Date
PL1856140T3 true PL1856140T3 (pl) 2014-06-30

Family

ID=34960696

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05707463T PL1856140T3 (pl) 2005-02-17 2005-02-17 Związane z matrycą peptydomimetyki o strukturze spinki do włosów ze zwrotem beta wykazujące aktywność hamowania proteaz

Country Status (21)

Country Link
US (4) US8658604B2 (pl)
EP (1) EP1856140B1 (pl)
JP (1) JP4896892B2 (pl)
KR (3) KR101443171B1 (pl)
CN (1) CN101142228A (pl)
AU (1) AU2005327825B2 (pl)
BR (1) BRPI0520016B1 (pl)
CA (3) CA2598360C (pl)
CY (1) CY1115084T1 (pl)
DK (1) DK1856140T3 (pl)
EA (1) EA013814B1 (pl)
ES (1) ES2453540T3 (pl)
HK (1) HK1213914A1 (pl)
IL (1) IL184804A (pl)
MX (1) MX2007009873A (pl)
NO (1) NO342041B1 (pl)
NZ (1) NZ556747A (pl)
PL (1) PL1856140T3 (pl)
PT (1) PT1856140E (pl)
SI (1) SI1856140T1 (pl)
WO (1) WO2006087001A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0520016B1 (pt) * 2005-02-17 2021-11-16 Polyphor Ltd. Composto, composiqao farmaceutica, uso de composto e processo para a fabricaqao de composto
WO2007079597A1 (en) 2006-01-16 2007-07-19 Polyphor Ltd. Template - fixed peptidomimetics with antimicrobial activity
US8633163B2 (en) * 2007-01-29 2014-01-21 Polyphor Ltd. Template-fixed peptidomimetics
KR101479148B1 (ko) 2007-02-28 2015-01-05 폴리포 리미티드 주형 고정된 펩타이드 모방체
EP2324047B1 (en) * 2008-08-08 2015-02-25 Polyphor AG Template-fixed peptidomimetics
HRP20221046T1 (hr) * 2013-12-27 2023-01-20 Spexis Ag Beta-ukosni peptidomimetici kao selektivni inhibitori elastaze
JP6499182B2 (ja) * 2013-12-27 2019-04-10 ポリフォー・アクチェンゲゼルシャフトPolyphor Ag 選択的エラスターゼ阻害剤としてのβ−ヘアピンペプチド模倣体
US20170319643A1 (en) 2016-05-05 2017-11-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv Lipoprotein targeting protease inhibitors and uses
LT3463281T (lt) * 2016-05-31 2022-09-26 Spexis Ag Beta-plaukų segtuko formos peptidomimetikai su elastazės inhibitoriniu aktyvumu ir aerozolinės jo dozavimo formos
CA3214455A1 (en) * 2021-03-22 2022-09-29 Peptiaid Inc Peptide and peptide-containing composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207502A (pt) * 2001-02-23 2004-03-09 Polyphor Ltd Compostos, enanciÈmeros, composição farmacêutica, uso de compostos, e, processo para a fabricação de compostos
CN101157924A (zh) * 2001-12-11 2008-04-09 人体基因组科学有限公司 嗜中性白细胞因子α
AU2002342618C1 (en) * 2002-08-20 2008-10-30 Polyphor Ltd. Template-fixed peptidomimetics with antibacterial activity
DE60226351T2 (de) 2002-10-02 2008-12-11 Polyphor Ltd. Matrizenfixierte peptidomimetika mit antimikrobieller wirkung
WO2004096838A1 (en) * 2003-05-02 2004-11-11 Polyphor Ag Template-fixed peptidomimetics as medicaments against hiv and cancer
AU2003232253A1 (en) 2003-05-02 2004-11-23 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
BRPI0520016B1 (pt) * 2005-02-17 2021-11-16 Polyphor Ltd. Composto, composiqao farmaceutica, uso de composto e processo para a fabricaqao de composto
US9073973B2 (en) * 2005-05-02 2015-07-07 Polyphor Ltd. Dye conjugates of template-fixed peptidomimetics
WO2007079597A1 (en) * 2006-01-16 2007-07-19 Polyphor Ltd. Template - fixed peptidomimetics with antimicrobial activity

Also Published As

Publication number Publication date
NZ556747A (en) 2009-09-25
AU2005327825B2 (en) 2012-02-16
AU2005327825A1 (en) 2006-08-24
KR20070106775A (ko) 2007-11-05
PT1856140E (pt) 2014-03-27
ES2453540T3 (es) 2014-04-08
EP1856140B1 (en) 2013-12-25
US10100084B2 (en) 2018-10-16
CA2915175A1 (en) 2006-08-24
HK1213914A1 (zh) 2016-07-15
BRPI0520016A2 (pt) 2009-08-18
NO342041B1 (no) 2018-03-12
US20140213531A1 (en) 2014-07-31
JP4896892B2 (ja) 2012-03-14
MX2007009873A (es) 2008-02-12
CN101142228A (zh) 2008-03-12
IL184804A (en) 2016-05-31
JP2008531485A (ja) 2008-08-14
CA2598360A1 (en) 2006-08-24
US8658604B2 (en) 2014-02-25
EP1856140A1 (en) 2007-11-21
IL184804A0 (en) 2007-12-03
EA200701727A1 (ru) 2008-04-28
KR101443171B1 (ko) 2014-09-22
WO2006087001A1 (en) 2006-08-24
KR101272633B1 (ko) 2013-06-10
KR20120127530A (ko) 2012-11-21
CA3035941C (en) 2021-11-16
CY1115084T1 (el) 2016-12-14
DK1856140T3 (en) 2014-03-10
NO20074674L (no) 2007-11-16
EA013814B1 (ru) 2010-08-30
KR101420198B1 (ko) 2014-08-13
CA2598360C (en) 2016-12-20
CA2915175C (en) 2019-04-09
CA3035941A1 (en) 2006-08-24
BRPI0520016B1 (pt) 2021-11-16
KR20130018449A (ko) 2013-02-22
US20190002498A1 (en) 2019-01-03
US20160333051A1 (en) 2016-11-17
US10562933B2 (en) 2020-02-18
SI1856140T1 (sl) 2014-04-30
US20090054345A1 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
IL184804A0 (en) Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
LT1981519T (lt) Proteazės slopinimas
IL187815A0 (en) Aspartyl protease inhibitors
IL187814A0 (en) Aspartyl protease inhibitors
IL187623A0 (en) Aspartyl protease inhibitors
GB0523954D0 (en) Bioassays
EP1854793A4 (en) NEW AMINOPYRIDEIN COMPOUND WITH SYK-HEMDERING EFFECT
AP2008004473A0 (en) Wear assembly
EP1898991A4 (en) PROTEIN ACTIVITY MODIFICATION
EP2172453A4 (en) COMPOUND HAVING 11 ß-HSD1 INHIBITION ACTIVITY
ZA200707227B (en) Novel aminopyridine compound with syk inhibitory activity
GB0513841D0 (en) Cysteine protease inhibitors
GB0504345D0 (en) Cryostat assembly
GB0513840D0 (en) Cysteine protease inhibitors
GB0513839D0 (en) Cysteine protease inhibitors
ZA200706347B (en) Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
IL196717A0 (en) 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
GB0518569D0 (en) Switch arrangement
GB0507628D0 (en) Protease inhibitors
GB0507627D0 (en) Protease inhibitors
GB0522994D0 (en) Slate save
GB0521886D0 (en) Glycosyltrasferase activity
GB0509245D0 (en) Macrocyclic peptidomimetics
GB0502165D0 (en) Peptide analysis
AU2005905564A0 (en) Protease inhibitors